###begin article-title 0
###xml 55 60 <span type="species:ncbi:9606">Human</span>
Comparative Methylation of ERVWE1/Syncytin-1 and Other Human Endogenous Retrovirus LTRs in Placenta Tissues
###end article-title 0
###begin p 1
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human endogenous retroviruses (HERVs) are globally silent in somatic cells. However, some HERVs display high transcription in physiological conditions. In particular, ERVWE1, ERVFRDE1 and ERV3, three proviruses of distinct families, are highly transcribed in placenta and produce envelope proteins associated with placenta development. As silencing of repeated elements is thought to occur mainly by DNA methylation, we compared the methylation of ERVWE1 and related HERVs to appreciate whether HERV methylation relies upon the family, the integration site, the tissue, the long terminal repeat (LTR) function or the associated gene function. CpG methylation of HERV-W LTRs in placenta-associated tissues was heterogeneous but a joint epigenetic control was found for ERVWE1 5'LTR and its juxtaposed enhancer, a mammalian apparent LTR retrotransposon. Additionally, ERVWE1, ERVFRDE1 and ERV3 5'LTRs were all essentially hypomethylated in cytotrophoblasts during pregnancy, but showed distinct and stage-dependent methylation profiles. In non-cytotrophoblastic cells, they also exhibited different methylation profiles, compatible with their respective transcriptional activities. Comparative analyses of transcriptional activity and LTR methylation in cell lines further sustained a role for methylation in the control of functional LTRs. These results suggest that HERV methylation might not be family related but copy-specific, and related to the LTR function and the tissue. In particular, ERVWE1 and ERV3 could be developmentally epigenetically regulated HERVs.
###end p 1
###begin title 2
Key words
###end title 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C1">1</xref>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C1">1</xref></sup>
###xml 529 530 529 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C2">2</xref>
###xml 529 530 529 530 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C2">2</xref></sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 71 76 <span type="species:ncbi:9606">human</span>
Human endogenous retroviruses (HERVs) are constitutive elements of the human genome.1 Now transmitted exclusively in a Mendelian way, they derived through infectious retrovirus integration in the germ-line DNA and transmission to the offspring, millions of years ago. Different waves of retroviral endogenization and expansion by retrotranspositional events (copying mechanism) led to the formation of at least 31 phylogenic multicopy families of HERVs, corresponding to over 400 000 HERV copies, dispersed throughout the genome.2 Because of the accumulation of mutations, the contemporary HERV families consist of collections of heterogeneous HERV elements, ranging from full-length proviruses [gag, pol and env gene sequences flanked at each extremity by a long terminal repeat (LTR)] to isolated LTRs derived from inter-LTR recombination events.
###end p 4
###begin p 5
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C3">3</xref>
###xml 244 245 244 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C4">4</xref>
###xml 242 245 242 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C3">3</xref>,<xref ref-type="bibr" rid="DSP011C4">4</xref></sup>
###xml 582 583 582 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C5">5</xref>
###xml 582 583 582 583 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C5">5</xref></sup>
###xml 725 726 725 726 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C6">6</xref>
###xml 725 726 725 726 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C6">6</xref></sup>
###xml 790 791 790 791 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C7">7</xref>
###xml 790 791 790 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C7">7</xref></sup>
###xml 820 821 820 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C8">8</xref>
###xml 820 821 820 821 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C8">8</xref></sup>
###xml 868 869 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C9">9</xref>
###xml 868 869 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C9">9</xref></sup>
###xml 924 926 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C10">10</xref>
###xml 924 926 924 926 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C10">10</xref></sup>
###xml 1065 1066 1065 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C9">9</xref>
###xml 1067 1069 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 1070 1072 1070 1072 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C12">12</xref>
###xml 1065 1072 1065 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C9">9</xref>,<xref ref-type="bibr" rid="DSP011C11">11</xref>,<xref ref-type="bibr" rid="DSP011C12">12</xref></sup>
###xml 1103 1104 1103 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C9">9</xref>
###xml 1103 1104 1103 1104 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C9">9</xref></sup>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C13">13</xref>
###xml 1127 1129 1127 1129 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C13">13</xref></sup>
###xml 1169 1171 1169 1171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 1172 1174 1172 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C14">14</xref>
###xml 1169 1174 1169 1174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref>,<xref ref-type="bibr" rid="DSP011C14">14</xref></sup>
###xml 1231 1233 1231 1233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C15">15</xref>
###xml 1231 1233 1231 1233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C15">15</xref></sup>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C13">13</xref>
###xml 1276 1278 1276 1278 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C13">13</xref></sup>
###xml 1347 1349 1347 1349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 1350 1352 1350 1352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C16">16</xref>
###xml 1353 1355 1353 1355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C17">17</xref>
###xml 1347 1355 1347 1355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref>,<xref ref-type="bibr" rid="DSP011C16">16</xref>,<xref ref-type="bibr" rid="DSP011C17">17</xref></sup>
Some families or family members of HERVs are naturally expressed in particular physiological contexts and display physiological functions. This is not only the case in several LTRs active as alternative promoters of cellular genes in placenta3,4 but also in proviruses driving the expression of their own retroviral protein, e.g. ERVWE1, ERVFRDE1 and ERV3, three phylogenically unrelated proviruses highly active in the placenta. ERVWE1 belongs to the HERV-W family and contains gag and pol pseudogenes but its envelope gene ORF has been preserved (for review see Gimenez and Mallet5). This domesticated envelope, dubbed Syncytin-1, was demonstrated to be involved in trophoblast fusion occurring during placental development6 and was also recently proposed to exert anti-apoptotic function7 and to induce proliferation.8 The ERVFRDE1 provirus from the HERV-FRD family9 and the ERV3/envR provirus from the ERV3/HERV-R family10 also code for functional envelope proteins that probably play a role in placental development, i.e. Syncytin-2 and ERV3 Env, respectively.9,11,12 Syncytin-2, which is fusogenic9 and immunosuppressive,13 appears strictly expressed in placenta.11,14 In contrast, ERV3 Env, which inhibits cell proliferation15 and exhibits immunosuppressive properties,13 is transcribed at various levels in almost all investigated tissues.11,16,17 Except for these few examples of localized physiological activities, HERV elements appear essentially silent in somatic cells.
###end p 5
###begin p 6
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C18">18</xref>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C19">19</xref>
###xml 405 410 405 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C18">18</xref>,<xref ref-type="bibr" rid="DSP011C19">19</xref></sup>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C20">20</xref>
###xml 556 558 556 558 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C20">20</xref></sup>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C21">21</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C23">23</xref>
###xml 696 701 696 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C21">21</xref>&#8211;<xref ref-type="bibr" rid="DSP011C23">23</xref></sup>
###xml 772 780 772 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C24">24</xref>
###xml 831 833 831 833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C24">24</xref></sup>
###xml 1027 1029 1027 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C25">25</xref>
###xml 1030 1032 1030 1032 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C26">26</xref>
###xml 1027 1032 1027 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C25">25</xref>,<xref ref-type="bibr" rid="DSP011C26">26</xref></sup>
###xml 1032 1039 1032 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 1165 1167 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C26">26</xref>
###xml 1168 1170 1168 1170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C30">30</xref>
###xml 1165 1170 1165 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C26">26</xref>&#8211;<xref ref-type="bibr" rid="DSP011C30">30</xref></sup>
###xml 1192 1194 1192 1194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C31">31</xref>
###xml 1195 1197 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C34">34</xref>
###xml 1192 1197 1192 1197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C31">31</xref>&#8211;<xref ref-type="bibr" rid="DSP011C34">34</xref></sup>
###xml 1260 1262 1260 1262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C22">22</xref>
###xml 1263 1265 1263 1265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C23">23</xref>
###xml 1260 1265 1260 1265 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C22">22</xref>,<xref ref-type="bibr" rid="DSP011C23">23</xref></sup>
###xml 1496 1498 1496 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C35">35</xref>
###xml 1496 1498 1496 1498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C35">35</xref></sup>
###xml 1547 1549 1547 1549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C36">36</xref>
###xml 1547 1549 1547 1549 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C36">36</xref></sup>
###xml 1585 1587 1585 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C25">25</xref>
###xml 1585 1587 1585 1587 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C25">25</xref></sup>
###xml 1632 1634 1632 1634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C37">37</xref>
###xml 1632 1634 1632 1634 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C37">37</xref></sup>
###xml 817 823 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 901 907 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 1554 1559 <span type="species:ncbi:9606">human</span>
HERV silencing is thought to be the result of the methylation of the LTRs (5' LTR, 3' LTR or solo LTR), which, as for infectious retroviruses, contain the regulatory elements and, in particular, the retroviral promoter in the LTR U3-subregion. This epigenetic process, which occurs in mammals on cytosines of 5'CpG dinucleotides, has the property to block the regulatory function of the targeted sequence.18,19 It is believed to have evolved primarily as a defense mechanism against the possible deleterious effects of retroelements and repeated sequences.20 Indeed, whole genome methylation studies showed that repeated elements, including HERVs, are globally methylated in normal somatic cells.21-23 Methylation-mediated repression of HERV LTRs activity was illustrated in vitro by methylation assays on functional HERV-K 5'LTRs.24 Conversely, demethylation-mediated derepression of copies from the HERV-K (HML-2) and HERV-E families was illustrated in cell culture by the use of the demethylating agent 5'-aza-deoxycytidine.25,26In vivo HERV transcripts have been detected in numerous pathological situations and predominantly in autoimmune/inflammatory diseases26-30 and tumoral contexts.31-34 Methylation deregulations are strongly associated with tumors,22,23 and interestingly, tumoral transcriptional reactivations of HERVs have been associated with LTRs hypomethylation for some contexts when compared with normal tissues. This is the case of one HERV-H copy in gastrointestinal cancers,35 several HERV- K members in urothelial carcinomas36 and human primary testicular tumors25 and the HERV-W family in ovarian carcinomas.37
###end p 6
###begin p 7
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C38">38</xref>
###xml 361 363 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C38">38</xref></sup>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C39">39</xref>
###xml 521 523 521 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C39">39</xref></sup>
###xml 757 759 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C40">40</xref>
###xml 760 762 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C41">41</xref>
###xml 757 762 745 750 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C40">40</xref>,<xref ref-type="bibr" rid="DSP011C41">41</xref></sup>
###xml 899 901 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C42">42</xref>
###xml 899 901 887 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C42">42</xref></sup>
###xml 1182 1184 1170 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C43">43</xref>
###xml 1185 1187 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C46">46</xref>
###xml 1182 1187 1170 1175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C43">43</xref>&#8211;<xref ref-type="bibr" rid="DSP011C46">46</xref></sup>
Thus, the impact of DNA methylation in the control of HERV elements seems obvious. However, HERV methylation status in physiological conditions has been less considered. HERV-E LTRs acting as alternative promoters of cellular genes in placenta were shown to be unmethylated in this tissue, but hypermethylated in blood where they do not exert promoter function.38 Likewise, the expression of the domesticated ERVWE1 locus has been correlated with hypomethylation of its 5'LTR in placenta in comparison with other tissues.39 Thus, HERV activity in physiological context seems related to a lack of methylation. The HERV-W family contains approximately80 full-length proviruses with flanking LTRs, 200 retrosequences with incomplete LTRs and 400 solitary LTRs.40,41 However, in contrast to ovarian carcinoma, expression of HERV-W family in placenta mainly results from the activity of the ERVWE1 locus.42 The high and specific placental expression of ERVWE1 has been attributed to the co-optation of its own retroviral promoter, localized in the 5' LTR, with an LTR retrotransposon of MaLR (mammalian apparent LTR retrotransposon) type, acting as a trophoblast-specific enhancer (TSE).43-46 Still neither the methylation status of this enhancer LTR nor the methylation status of family related LTRs is known. Similarly, the methylation status of other proviruses producing envelope proteins, like ERVFRDE1 and ERV3, are unknown.
###end p 7
###begin p 8
Generally, the features determining HERV methylation status are unknown. In addition, it remains poorly understood whether methylation not only can repress but also regulate HERV activity. Here, we asked whether ERVWE1 5'LTR methylation is related to the HERV family, the LTR role, the LTR-surrounding genomic context, the tissue or the implication of its envelope gene in a physiological process. For this purpose, we investigated and compared the methylation profiles of ERVWE1 5'LTR with ERVWE1 MaLR LTR enhancer, different HERV-W LTRs and the 5'LTRs from HERVs probably involved in placenta development and maintenance. Whether transcriptional activity and methylation were correlated was further addressed using model cell lines.
###end p 8
###begin title 9
Materials and methods
###end title 9
###begin title 10
Biological samples
###end title 10
###begin p 11
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C47">47</xref>
###xml 1298 1300 1298 1300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C49">49</xref>
###xml 1295 1300 1295 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C47">47</xref>&#8211;<xref ref-type="bibr" rid="DSP011C49">49</xref></sup>
###xml 1545 1547 1545 1547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C50">50</xref>
###xml 1545 1547 1545 1547 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C50">50</xref></sup>
###xml 1577 1578 1577 1578 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 701 706 <span type="species:ncbi:9606">woman</span>
Placental tissues from the first trimester legally induced abortions (8-12 weeks of gestation) were obtained from the Department of Obstetrics and Gynecology at the Broussais, Saint Vincent de Paul and Cochin Hospitals. Second trimester placental tissues were collected at the time of termination of pregnancy at 15 and 25 weeks of gestation (in weeks of amenorrhea) in trisomy 21-affected pregnancies. Fetal Down syndrome was diagnosed by karyotyping of amniotic fluid cells. The indication of amniocentesis was the maternal age. Term placentas were obtained after elective cesarean section from healthy mothers near term with uncomplicated pregnancies. With written informed consent of the pregnant woman, the following samples were collected at term: a fragment of the placenta, umbilical cord fetal blood and maternal blood. The placenta biopsy sample was collected at a depth of 1 cm and at a distance of 8 cm from the edge of the placenta, with the maternal side facing upward. The use of these biological samples was approved by local ethical committee. Villous cytotrophoblastic cells were isolated by sequential enzymatic digestion of chorionic villi from the first trimester, second trimester and term placenta and purified on a discontinuous percoll gradient, as described previously.47-49 These cells were positively stained for cytokeratin 7 at 95%, indicating the cytotrophoblastic origin of the cells. Placental fibroblasts were isolated by prolonged enzymatic digestion from first trimester chorionic villi as in Malassine et al.50 Fibroblastic cells (1.25 x 105 cells/mL) were plated on 35-mm plastic dishes (TPP, Switzerland) and cultured for 48 h, and the culture medium was changed daily. These cultured fibroblasts were characterized using immunocytochemistry. It was found that 98% of the cells were vimentin positive and also positive for a monoclonal antibody against specific fibroblast antigen (clone ASO2, Dianova, Hamburg, Germany). Owing to the limited amount of cells, only DNA was extracted.
###end p 11
###begin title 12
Cell lines
###end title 12
###begin p 13
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 127 131 <span type="species:ncbi:9913">calf</span>
###xml 158 163 <span type="species:ncbi:9606">Human</span>
###xml 295 300 <span type="species:ncbi:9606">Human</span>
Human choriocarcinoma cells BeWo b30 were cultured in F-12K medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal calf serum (FCS) (Invitrogen). Human ovarian carcinoma cells OVCAR-3 were cultured in the RPMI 1460 medium supplemented with 20% FCS (LGC Promochem, Molsheim, France). Human astrocytoma cells 85HG66 were cultured in the DMEM medium (Invitrogen) supplemented with 10% FCS (Invitrogen). Monocytoid cells U937 were cultured in the RPMI 1640 medium containing 10% FCS. All media were supplemented with antibiotics, i.e. 100 IU of penicillin/mL, 100 microg of streptomycin/mL and 0.25 microg/mL amphotericin B (Fungizone) (Invitrogen). Cells were maintained in culture until confluence before DNA and RNA extractions.
###end p 13
###begin title 14
Sodium bisulfite modification of genomic DNA
###end title 14
###begin p 15
###xml 346 348 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C51">51</xref>
###xml 346 348 344 346 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C51">51</xref></sup>
Genomic DNA from confluent cell lines, blood samples and villous placenta section was isolated using the Nucleospin(R)Blood or Tissue kit following the manufacturer's instructions (Macherey-Nagel). Genomic DNA from cytotrophoblasts and placental fibroblasts was obtained following the overnight proteinase K lysis and phenol extraction procedure.51 To perform methylation studies, genomic DNA was submitted to sodium bisulfite treatment. This procedure converts all methyl-free cytosines into uracils, whereas methylated cytosines remain unchanged. For each sample, 1 microg of genomic DNA was mixed with 3 microg of carrier pUC18 DNA in a final volume of 100 microL. The mixture was heated for 10 min at 65degreesC, and the DNA denatured in 20 microL NaOH 3N for 30 min at 37degreesC. To convert unmethylated cytosines, denatured DNA was incubated in 50 microL hydroquinone 0.1M and 350 microL sodium bisulfite 3M for 16 h at 50degreesC. Modified DNA was then purified using Wizard DNA Clean-up System (Promega) and eluted in 50 microL of sterile water. DNA modification was completed by incubation in 5 microL NaOH 3N for 15 min at room temperature. DNA was washed by precipitation for 30 min at -20degreesC in 10 microL of ammonium acetate 5M and 200 microL of absolute ethanol, followed by centrifugation at 13 000 rpm at 4degreesC for 10 min. An additional wash was realized by centrifugation in 500 microL ethanol 70% for 5 min. The DNA pellet was eluted in 30 microL of sterile water.
###end p 15
###begin title 16
DNA methylation analyses
###end title 16
###begin p 17
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSP011TB1">1</xref>
###xml 375 376 363 364 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 540 541 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSP011TB1">1</xref>
###xml 893 894 841 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSP011TB1">1</xref>
Strand-specific primers were designed to specifically amplify the HERV LTR copy of interest on bisulfite modified DNA by nested PCR (Table 1). First-round PCR was accomplished in a 50 microL mixture containing 3 microL of modified DNA, 0.66 microM of each primer, 1 mM of each dNTP, 1 U of DyNAzyme polymerase (Fynnzyme), 1x Mg-free DyNAzyme buffer (Fynnzyme) and 1.5 mM MgCl2 (Fynnzyme). PCR cycling conditions were: 5 min at 94degreesC; 35 cycles as follows: 1 min at 94degreesC, 2 min at a temperature depending on the primer set (Table 1), 1 min at 72degreesC; and a final extension at 72degreesC for 5 min. Nested PCR was performed on 1 microL of the first PCR products with internal primers in the same reaction mixture conditions. Nested PCR cycling conditions were 5 min at 94degreesC; 30 cycles as follows: 1 min at 94degreesC, 1 min at a temperature depending on a primer set (Table 1), 1 min at 72degreesC; and a final extension at 72degreesC for 5 min. PCR fragments were gel-extracted, cloned and sequenced using plasmid forward and reverse primers. To determine CpG methylation, and cytosine conversion rate, the sequence of each clone was aligned and compared with the in silico modified reference sequence (with all cytosines converted into thymines independently of their context). CpG positions were located and the methylation status at each CpG site observed. To prevent false-positive interpretation, only sequences with more than 95% of converted bases (all cytosines out of CpG context) were taken in analyses. Independence of the sequences was determined based either on their within-sample unique methylation pattern and/or on unique non-conversion of cytosines out of CpG context. For some samples, conversion rate was too high to determine the molecular independence of sequences based on unconverted cytosines. In these cases, more than 10 sequences were systematically analyzed to ensure methylation pattern representativity, and results were confirmed on other samples.
###end p 17
###begin p 18
Primer sets used for determination of HERV LTRs methylation
###end p 18
###begin p 19
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 145 146 145 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</bold>
###xml 156 157 156 157 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</bold>
aNucleotides in bold and lowercase letters represent changes in primers relative to the genomic sequence due to bisulfite treatment, as follows: t is C and a is G in the untreated sequence. The position relative to the LTR start is given in parentheses.
###end p 19
###begin title 20
Real-time qRT-PCR
###end title 20
###begin p 21
###xml 149 150 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="DSP011TB2">2</xref>
###xml 244 280 244 280 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://genome.ucsc.edu/cgi-bin/hgPcr">http://genome.ucsc.edu/cgi-bin/hgPcr</uri>
###xml 209 214 <span type="species:ncbi:9606">human</span>
HERV LTR-derived transcript-specific primer sequences were determined using Oligo 6 software (MBI, Cascade, USA) or taken from published work (Table 2). Systems specificity was checked by in silico PCR on the human genome (UCSC Genome Browser: http://genome.ucsc.edu/cgi-bin/hgPcr; reference assembly: March 2006).
###end p 21
###begin p 22
Primer sets used for analyses of HERV LTR-derived transcriptional activity
###end p 22
###begin p 23
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 24 26 24 26 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 24 26 24 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref></sup>
aFrom De Parseval et al.11
###end p 23
###begin p 24
###xml 197 200 197 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">260</sub>
Total RNA was isolated using the RNeasy Midi Kit including an on-column DNAse treatment in accordance with the manufacturer's instructions (Qiagen, Hilden, Germany). RNA quantity was measured at OD260 in a spectrophotometer, and RNA quality was assessed with a Bioanalyzer capillary electrophoresis device (Agilent, Palo Alto, USA). For each sample, 5 microg of total RNA was converted into cDNA in a final volume of 20 microL with random hexamer primers using ThermoScript RT-PCR System for first-strand cDNA synthesis (Invitrogen) following the manufacturer's recommendations. Reverse-transcriptase-free reactions were carried out simultaneously to verify the absence of contaminating genomic DNA.
###end p 24
###begin p 25
Real-time PCRs were performed with the Stratagene Mx3005P quantitative PCR system (Stratagene, La Jolla, CA, USA) using the SYBR (with dissociation curve) option. Each quantitative PCR was performed on 10 microL of 100-fold diluted cDNA, in a PCR mix containing 0.2 microM of individual target primers, 10 microL of 2x Brilliant SYBR Green QPCR Master Mix (Stratagene) and water to reach a volume of 25 microL. Housekeeping genes were analyzed in the same experiment as the target transcripts. The experiments were performed in duplicate and included RT-minus controls. Following a 10 min denaturation at 95degreesC, gene amplification was performed as follows: 40 cycles at 95degreesC for 30 s, 55degreesC for 1 min and 72degreesC for 30 s. Melting curve acquisition was performed within a 55-95degreesC range, and resulting amplicons were sequenced and analyzed to check for false-positive detection. 18S and HPRT were the most stable housekeeping genes among the samples (variation less than a factor of 4.05 and 4.25, respectively). The geometric mean of their expression average was calculated and used to normalize for differences in the amount of total RNA added to the reaction. The relative quantification of transcripts was then calculated with respect to an external standard calibration curve established using serial dilutions of purified genomic DNA amplification products. The copy number of LTR-derived transcripts was related to 1000 cells, corresponding to approximately12.5 ng of total RNA.
###end p 25
###begin title 26
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro methylation of ERVWE1 promoter constructs and luciferase assays
###end title 26
###begin p 27
###xml 283 285 283 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C43">43</xref>
###xml 283 285 283 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C43">43</xref></sup>
###xml 429 430 425 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S</italic>
To investigate the influence of methylation on the different regulatory regions of the ERVWE1 promoter activity, we used the previously described reporter plasmid pGL3-basic firefly luciferase HW-67/310 (TSE-U3), HW-1/310 (U3 full-length) and HW-90/310 (minimal promoter) constructs.43 Three micrograms of each pGL3-LTR vectors were methylated in a reaction mix containing 4 U of SssI CpG methylase, 1x NEBuffer 2 and 160 microM S-adenosyl-methionine (SAM) in a final volume of 20 microL (New England Biolabs). The methylation reactions were realized at 37degreesC and stopped after 30, 60, 120 and 240 min by heat inactivation of SssI at 65degreesC for 20 min. The negative control (no methylation) underwent the same treatment lacking SAM. To determine the methylation level of each reaction, 500 ng aliquots were digested with 0.5 U BstUI methylation-sensitive endonuclease (New England Biolabs) in 1x NEBuffer for 1 h at 60degreesC, and restriction profiles were analyzed after electrophoresis on a 1% agarose gel. BeWo b30 choriocarcinoma cells at 60-70% confluence were seeded in 12-well plates. Twenty-four hours later, cells were co-transfected with 0.7 microg of pGL3-LTR firefly luciferase plasmid either methylated or not (-SAM) and 35 ng of pRL-TK Renilla luciferase plasmid for internal standardization (Kit Dual-Luciferase(R) Reporter Assay System, Promega) by use of Lipofectamine Plus (GibcoBRL-Life Technologies, Invitrogen) as recommended by the manufacturer. Cells were lysed 24 h after transfection with passive lysis buffer (Promega). Firefly and Renilla luciferase activities were measured by using the Dual-Luciferase(R) Reporter Assay 1000 System (Promega) according to the manufacturer's instructions. Promoter activities were normalized to the internal Renilla luciferase control, i.e. (Firefly luciferase activity/Renilla luciferase activity) x 100. All reporter gene assays were performed in triplicate.
###end p 27
###begin title 28
Results and discussion
###end title 28
###begin title 29
Methylation of HERV-W LTRs in placenta and placenta-associated tissues
###end title 29
###begin title 30
Description of the investigated HERV-W LTRs
###end title 30
###begin p 31
###xml 293 295 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C43">43</xref>
###xml 296 298 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C46">46</xref>
###xml 293 298 281 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C43">43</xref>,<xref ref-type="bibr" rid="DSP011C46">46</xref></sup>
###xml 1329 1330 1317 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F1">1</xref>
ERVWE1/Syncytin-1 (Ch7q21.2; AC007566) transcription is regulated by two distinct elements, i.e. the ERVWE1 5'LTR U3 promoter region and an adjacent upstream TSE. This enhancer is located within a MaLR solo LTR within which the ERVWE1 provirus integrated approximately25-40 millions years ago.43,46 We chose to analyze together the methylation status of these two co-opted but unrelated LTRs involved in Syncytin-1 regulation, further referred to as MaLR[LTR]-ERVWE1[5'LTR]. As a minimal model to test the family related methylation process hypothesis, three other HERV-W LTRs were studied: ERVWE1[3'LTR], HW_4[5'LTR] and HW_12[solo LTR]. ERVWE1[3'LTR] is the 3'LTR of ERVWE1 provirus and represents topographically and phylogenetically the closest HERV-W LTR relative to ERVWE1[5'LTR]. HW_4[5'LTR] is an another functional (data not shown) 5'LTR belonging to a HERV-W provirus located on chromosome 4 (Ch4p13; AC024 022). HW_12[solo LTR] is a full-length solitary HERV-W LTR localized on chromosome 12 (Chr12q24.32; AC005868), and a cDNA overlapping the 51 bp at the 3' end of the U5 region was found to have 100% identity with this part of the U5 region (BC038735). These HERV-W LTRs exhibit common but also specific CpG sites. An alignment of the investigated LTR U3 regions with highlighted CpG location is presented in Fig. 1. About 200 bp of the upstream env region from the ERVWE1[3'LTR] and approximately100 bp of the upstream region from the HW_4[5'LTR], which contains a MER110 type LTR, were co-amplified with the respective HERV-W LTRs as controls of genomic environment methylation.
###end p 31
###begin p 32
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C45">45</xref>
###xml 215 217 215 217 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C45">45</xref></sup>
Alignment of HERV-W LTR U3 promoter. ERVWE1[5'LTR] and ERVWE1[3'LTR] U3 region allelic forms were previously determined on DNA amplified from 24 individuals (e.g. -132A. individual 132, allele A), i.e. 48 sequences.45 HW_12[solo LTR] and HW_4[5'LTR] allelic forms derive from the annotated genome sequence (-A, reference allele; -B, alternative allele; SNP ID, rs6489086). Proportion of each allelic form is given in hooks (e.g. [3], 3 of the 48 sequences hold this allelic form; [nd], not determined). CAAT box, TATA box and transcription binding sites are indicated. Effective transcription factor binding sites are underlined; putative transcription factor binding sites are marked by interrupted lines. CpG sites are indicated by gray background, their position in the U3 region is given relative to ERVWE1 5'LTR sequence.
###end p 32
###begin title 33
Methylation unequally affects ERVWE1 5'LTR and other HERV-W LTRs
###end title 33
###begin p 34
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
The methylation profiles of ERVWE1 and related HERV-W LTRs were investigated in villous placenta and in non-trophoblastic cells composing the placenta, i.e. placental fibroblasts, fetal blood cells and maternal blood cells (Fig. 2).
###end p 34
###begin p 35
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 785 788 785 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 790 793 790 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 912 913 912 913 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 914 915 914 915 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 937 938 937 938 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 966 967 966 967 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 976 979 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 989 990 989 990 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1009 1010 1009 1010 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1733 1736 1733 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
CpG methylation of HERV-W LTRs in placenta-associated tissues. (A) Schematic representation of MaLR[LTR]-ERVWE1[5'LTR], ERVWE1[env-3'LTR], HW_4[5'LTR] and HW_12[solo LTR] analyzed regions. LTR regions are represented by boxes and CpG dinucleotides by circles on vertical bars. The U3 region (light gray) constitutes the retroviral promoter, transcription starts at the U3/R boundary (arrow). For each LTR, CAAT and TATA boxes as well as putative and effective transcription factor binding sites proximal to or containing CpG are indicated. Symbols above CpGs point out conserved CpGs between the different LTRs, asterisk indicates CpGs conserved in all three LTRs. TSE, trophoblast-specific enhancer of ERVWE1 provirus, located in the 5'part of the MaLR LTR (white box at the 5' end); env, env-3'UTR region of ERVWE1 provirus. The MER114 LTR located upstream from HW_4[5'LTR] is also represented (hatched box). (B-E) CpG methylation of (B) MaLR[LTR]-ERVWE1[5'LTR], (C) ERVWE1[env-3'LTR], (D) HW_4[5'LTR] and (E) HW_12[solo LTR]. Methylation was determined by bisulfite sequencing PCR in villous trophoblast of term placenta, related fetal and maternal blood cells and in placental fibroblasts from chorionic villi of a first trimester placenta. Each sample result originates from the same conversion reaction. Each line represents an independent clone as determined by methylation and/or conversion differences. Methylated CpG are schematized by black circles, unmethylated CpGs by white circles, the mutated CpG (SNP) in HW_12 is represented by a cross and CpGs with undetermined methylation state by gray circles. Global methylation percentages in the U3 regions (highlighted in gray) as well as in the upstream regions (MaLR LTR, env, MER114 LTR) are given below the respective area for each sample (in parentheses for non-U3 regions).
###end p 35
###begin p 36
###xml 61 62 61 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 148 149 148 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C38">38</xref>
###xml 365 367 365 367 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C38">38</xref></sup>
The phylogenetically related HERV-W LTRs schematized in Fig. 2A were found highly methylated in a majority of the investigated normal tissues (Fig. 2B-E). In blood particularly, the high global methylation of the HERV-W LTRs (from 85% to 98.2% of methylated CpGs) was similar to the methylation range observed for various LTRs of another HERV family, namely HERV-E.38 In placental fibroblast, all LTRs were also highly methylated (76.9-93.9% of methylated CpGs) except for HW_12[solo LTR] whose methylation level was found at its lowest (38.5%).
###end p 36
###begin p 37
###xml 659 661 623 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C39">39</xref>
###xml 659 661 623 625 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C39">39</xref></sup>
The villous placenta appeared to be the tissue with the lower level of methylation for all the LTRs except HW_12[solo LTR]. In spite of it, both the methylation levels and the methyl-group distribution within the molecules were different between the LTRs. Thus, CpG methylation level was low for ERVWE1[5'LTR] and HW_4[5'LTR] (approximately40%), whereas it was relatively high for ERVWE1[3'LTR] (approximately70%) and even higher for HW_12[solo LTR] (approximately80%). Methyl-group distribution on ERVWE1[5'LTR] was bimodal, as molecules were either unmethylated (7 out of 12 clones) or densely methylated. This feature, first described by Matouskova et al.,39 appeared to be specific to ERVWE1 promoter. The methylation defaults on the other HERV-W LTRs were more diffusely distributed. Thus, some molecules were found repeatedly unmethylated on definite CpG sites, solely or together with contiguous CpGs (e.g. the first CpG of ERVWE1[3'LTR] and the second CpG of HW_4[5'LTR]), but no molecule was found fully unmethylated. On the contrary, some other CpG sites were found constitutively methylated (e.g. the first CpG of HW_4[5'LTR], the last CpG of ERVWE1[3'LTR] and the last two CpGs of HW_12[solo LTR]).
###end p 37
###begin p 38
Interestingly in this tissue, the CpG site located at the end of the ERVWE1[5'LTR] ER binding site and conserved in ERVWE1[3'LTR] and HW_4[5'LTR] was not methylated in approximately the same proportion of clones in both LTRs (e.g. in 7 out of 10 clones and 9 out of 10 clones, respectively). Likewise, the CpG located before the TATA box, conserved in ERVWE1[3'LTR] and HW_12[solo LTR], was not methylated in 4 out of 10 clones and 4 out of 12 clones. However, other conserved CpGs did not have the same pro-rata of methylation default (e.g. the CpG at the U3/R border was not methylated in 2 out of 10 clones of ERVWE1[3'LTR] and 7 out of 10 of HW_4[5'LTR] and none of HW_12[solo LTR]), indicating that the ER binding site and TATA-box-associated CpGs might have particular methylation-targeting features.
###end p 38
###begin p 39
These results demonstrate that LTRs from the same phylogenetic lineage can be unequally methylated within the same cellular type, suggesting that methylation establishment on HERV sequences might not be family dependent.
###end p 39
###begin title 40
Methylation of ERVWE1 LTRs and associated MaLR LTR suggests a regional control
###end title 40
###begin p 41
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C39">39</xref>
###xml 248 250 248 250 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C39">39</xref></sup>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C46">46</xref>
###xml 463 465 463 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C46">46</xref></sup>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C52">52</xref>
###xml 526 528 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C52">52</xref></sup>
###xml 571 573 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C53">53</xref>
###xml 571 573 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C53">53</xref></sup>
###xml 984 986 984 986 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C52">52</xref>
###xml 984 986 984 986 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C52">52</xref></sup>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C54">54</xref>
###xml 1094 1096 1094 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C54">54</xref></sup>
###xml 1208 1241 1208 1241 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.essex.ac.uk/bs/molonc/spa.htm">www.essex.ac.uk/bs/molonc/spa.htm</uri>
###xml 533 538 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
By definition, ERVWE1[5'LTR] and ERVWE1[3'LTR] belong to the same proviral unit, but appeared differentially methylated in villous placenta. This unmethylation of the 5'LTR corresponds with its promoter function in placenta, as reported previously.39 The 3'LTR methylation in return may prevent a local competition with ERVWE1 5'LTR for promoter activity as well as a 3'LTR-derived transcriptional interference with the nearby antisense-oriented ODAG/GATAD1 gene.46 Such a differential methylation has been observed for HTLV-152 and HIV-1 proviruses during viral latency.53 For these two retroviruses, however, methylation favored repression of the 5'LTR promoter activity as the 5'LTR was methylated and the 3'LTR was not. This suggests different methylation features for exogenous/pathogenic and endogenous/domesticated proviruses but possibly a conserved strategy to prevent methylation spreading on both proviral LTRs, like the use of boundary elements as hypothesized for HTLV-1.52 The CTCF protein is a factor able to create boundaries between methylated and unmethylated genomic domains.54 Interestingly, two domains containing potential binding sites for CTCF were identified within ERVWE1 provirus (www.essex.ac.uk/bs/molonc/spa.htm), respectively, downstream from the 5' LTR and upstream from the 3' LTR region that we found methylated. Further investigations are required to ascertain CTCF functional relevance in the context of proviruses. Nevertheless, it appears that methylation might be regionally controlled and linked either to the genomic environment or to the LTR function.
###end p 41
###begin p 42
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 682 683 670 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 924 925 912 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 1103 1105 1091 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C38">38</xref>
###xml 1103 1105 1091 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C38">38</xref></sup>
The upstream flanking sequence of three out of the four HERV-W LTRs was amplified along with the respective LTRs. Except for one clone in the villous placenta tissue, the MaLR[LTR] directly upstream from ERVWE1 presented the same methylation profiles as the ERVWE1[5'LTR], i.e. either unmethylated, partially methylated or highly methylated (for methylation values, see Fig. 2B). In contrast, the CpG sites contained within the approximately200 bp of the env gene co-amplified with ERVWE1[3'LTR] appeared systematically highly methylated, including those in the villous placenta (with 92.5% of methylation level), despite a lower methylation (68%) of the 3'LTR in this tissue (Fig. 2C). Finally, methylation levels between HW_4[5'LTR] and the upstream MER114[LTR] part were similar in PBL and placental fibroblasts, but in the villous placenta, HW_4[5'LTR] methylation level was much lower (40%) than the MER114 (70%) (Fig. 2D). Thus, except for ERVWE1[5'LTR] and the upstream MaLR[LTR], there was no clear correlation between the methylation of the HERV-W LTRs and their flanking sequence. Reiss et al.38 also recently concluded that the hypomethylation of HERV-E LTRs acting as placenta promoters of cellular genes, when compared with random LTRs, cannot be explained by a difference in methylation of their flanking sequences, irrespective of its nature-repeated element or not.
###end p 42
###begin p 43
###xml 147 149 147 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C43">43</xref>
###xml 150 152 150 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C46">46</xref>
###xml 147 152 147 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C43">43</xref>,<xref ref-type="bibr" rid="DSP011C46">46</xref></sup>
###xml 496 499 496 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 516 525 516 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C45">45</xref>
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C45">45</xref></sup>
The MaLR[LTR] and the ERVWE1[5'LTR] elements have been earlier demonstrated to be co-opted and to specifically control ERVWE1 placental expression.43,46 Thus, although belonging to distinct LTR types, their shared unmethylation status in placenta could be linked to their involvement in the regulation of Syncytin-1 transcription. Likewise, the heavy methylation of both LTRs in non-placenta cells supports a repression process outside placenta. Overall, these results are compatible with ERVWE1 env regulation as a bona fide gene.45
###end p 43
###begin title 44
5'LTR methylation of HERVs coding for proteins associated with placenta morphogenesis
###end title 44
###begin title 45
Description of the placentally expressed HERV included in the study
###end title 45
###begin p 46
###xml 175 177 175 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C55">55</xref>
###xml 175 177 175 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C55">55</xref></sup>
###xml 489 491 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C12">12</xref>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C43">43</xref>
###xml 489 494 489 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C12">12</xref>,<xref ref-type="bibr" rid="DSP011C43">43</xref></sup>
###xml 572 592 572 592 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="www.repeatmasker.org">www.repeatmasker.org</uri>
###xml 738 743 <span type="species:ncbi:9606">human</span>
ERVFRDE1 Env (Syncytin-2) and ERV3 Env together with ERVWE1 Env (Syncytin-1) are the three retroviral envelope proteins exhibiting a probable function in placenta development.55 Syncytin-2 and ERV3 Env are, respectively, encoded by ERVFRDE1, a provirus belonging to the HERV-FRD family (HERV-FRD_6p24.1; AL136139) and the provirus ERV3 belonging to the ERV3/HERV-R family (HERV-R_7q11.2; AC073210). LTR borders and transcription start sites have already been published for ERVWE1 and ERV3.12,43 ERVFRDE1 LTR borders limits were determined using the RepeatMasker software (www.repeatmasker.org). ERVFRDE1[5'LTR] U3/R boundary, delineating the transcription start site, was located at nt +492 or nt +504 from the [5'LTR] 5' end, using four human placental full-length or 5' end containing mRNAs displaying more than 99% identity with ERVFRDE1 genomic sequence (BC068585, AK123938, AL543429 and CR626159).
###end p 46
###begin title 47
The 5'LTR of placentally expressed HERVs display dissimilar methylation profiles in placenta tissues
###end title 47
###begin p 48
###xml 121 122 121 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
We investigated and compared the 5'LTR methylation profiles of ERVWE1, ERVFRDE1 and ERV3 proviruses (schematized in Fig. 3A), in the same placenta-associated tissues as done for HERV-W LTRs. It appeared that all three 5'LTRs shared a common lack of methylation in villous placenta but under different modalities. In addition, their methylation was widely variable in the non-trophoblastic cells associated with the placenta.
###end p 48
###begin p 49
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F2">2</xref>
###xml 553 554 553 554 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 555 556 555 556 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 578 579 578 579 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 617 618 617 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F1">1</xref>
###xml 622 623 622 623 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 646 647 646 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
CpG methylation envelope-coding HERV 5'LTRs in placenta-associated tissues. (A) Schematic representation of MaLR[LTR]-ERVWE1[5'LTR] (as in Fig. 2A), ERVFRDE1[5'LTR] and ERV3[5'LTR] analyzed regions. LTR regions are represented by boxes and CpG dinucleotides by circles on vertical bars. The U3 region (light gray) constitutes the retroviral promoter, transcription starts at the U3/R boundary (arrow). Putative transcription factor binding sites proximal to or overlapping CpGs are indicated. Downstream horizontal bars are provirus internal sequence. (B-E) CpG methylation of (B) MaLR[LTR]-ERVWE1[5'LTR] (as in Fig. 1), (C) ERVFRDE1[5'LTR] and (D) ERV3[5'LTR]. Methylation was determined by bisulfite sequencing PCR in villous trophoblast of term placenta, related fetal and maternal blood cells and in placental fibroblasts from chorionic villi of a first trimester placenta. Each sample result originates from the same conversion reaction. Each line represents an independent clone as determined by methylation and/or conversion differences. Methylated CpG are schematized by black circles, unmethylated CpGs by white circles and CpGs with undetermined methylation state by gray circles. Global methylation percentage values in the U3 regions (highlighted in gray) as well as in the MaLR[LTR] (in parentheses) are given below the respective area for each sample.
###end p 49
###begin p 50
###xml 223 224 223 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
###xml 374 375 374 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
###xml 498 499 498 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 1017 1019 1017 1019 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref></sup>
In villous placenta, ERVWE1[5'LTR] had a global methylation level of 36.7%, and molecules were bimodally methylated, as mentioned above. An important amount of unmethylated molecules (7 out of 12 clones) was observed (Fig. 3B). In contrast, methylation of ERVFRDE1[5'LTR] was close to zero in the villous placenta, as only two CpGs were methylated in the whole sample (Fig. 3C). Finally, methylation of ERV3[5'LTR] reached a level of 23.5% and was distributed within three principal patterns (Fig. 3D). Thus, completely unmethylated molecules were found in high proportion (10 clones out of 17), completely methylated molecules were found in very low proportion (2 clones) and the remaining molecules were methylated only at the U3 area borders (5 clones). Although the methylation distribution of ERVWE1, ERVFRDE1 and ERV3 [5'LTRs] was undoubtedly different, an important amount of totally unmethylated clones was found for all three HERV 5'LTRs in agreement with their promoter function and activity in trophoblast.11
###end p 50
###begin p 51
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 888 890 888 890 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C14">14</xref>
###xml 891 893 891 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C50">50</xref>
###xml 885 893 885 893 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref>,<xref ref-type="bibr" rid="DSP011C14">14</xref>,<xref ref-type="bibr" rid="DSP011C50">50</xref></sup>
###xml 1051 1054 1051 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 1088 1090 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 1088 1090 1088 1090 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref></sup>
###xml 1511 1513 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C56">56</xref>
###xml 1511 1513 1511 1513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C56">56</xref></sup>
###xml 2177 2179 2177 2179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C11">11</xref>
###xml 2177 2179 2177 2179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C11">11</xref></sup>
###xml 2124 2129 <span type="species:ncbi:9606">human</span>
In placenta-associated non-trophoblastic cells, i.e. PBLs and placental fibroblasts, ERVWE1[5'LTR] was found heavily methylated. ERVFRDE1[5'LTR] was also essentially methylated in placental fibroblasts (77.9%), albeit CpGs 3, 5 and 8 were regularly unmethylated. In fetal cord blood cells on the contrary, the global methylation level of ERVFRDE1[5'LTR] was only 25.3%. This was due to a quasi-systematic but exclusive methylation on the CpGs neighboring the TATA box. This accurate methylation pattern was conserved in maternal blood cells, although an occasional methylation of the second CpG site slightly increased the methylation level up to 30.2%. ERVWE1 high methylation level in non-trophoblastic cells and ERVFRDE1 high methylation in placental fibroblasts are in agreement with the lack of expression previously established for ERVWE1 and ERVFRDE1 env mRNAs in these tissues.11,14,50 In spite of this, there is no trivial link between ERVFRDE1[5'LTR] low methylation level in PBLs and the described weak transcriptional activity of ERVFDRE1 env (200-fold less than in placenta).11 One explanation could be that essential transcription factors needed for ERVFRDE1 transcriptional activity are missing in PBL. Nonetheless, another explanation could be related to the precise and accurate methylation at only the CpGs closed to the TATA box. Such a local methylation was observed for the RANKL gene promoter and impaired transcriptional induction by disturbing the attachment of the TATA binding protein.56 Contrary to ERVWE1 and ERVFRDE1, methylation patterns of ERV3[5'LTR] in maternal blood cells and placental fibroblasts were highly similar to those found in term trophoblast. However, the proportion of each pattern and consequently the global methylation level varied depending on the sample type. Thus, the global methylation of the ERV3 5'LTR U3 region reached 37.5% in maternal blood (with 6 unmethylated clones out of 16) and 54.6% in placental fibroblasts (with 2 unmethylated clones out of 11). The variation in their relative proportion could explain the variable levels of ERV3 env transcription among human tissues in general and between placenta and PBL11 in particular. An exception to this trend of ERV3[5'LTR] generic methylation patterns was the finding of only one methylated CpG (equivalent to 1.9% of total methylation) in the fetal cord PBLs sample. This lack of methylation was all the more unexpected, since the LTRs of all the other HERVs analyzed in this study had a conserved methylation in fetal and adult PBLs. Whether this lack of methylation correlates with significant ERV3 env mRNA and protein levels in fetal PBLs deserves further investigation.
###end p 51
###begin p 52
In conclusion, methylation status of these LTRs is globally in adequation with their respective promoter activity and could also be implicated in the modulation of their transcriptional level and consequently in the biological activity of their protein.
###end p 52
###begin title 53
Pregnancy-associated 5'LTR methylation changes in HERV coding for envelope proteins in cytotrophoblasts
###end title 53
###begin p 54
###xml 26 29 26 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
ERVWE1, ERVFRDE1 and ERV3 env expression is localized in cytotrophoblastic cells of the placenta and is temporally regulated during pregnancy, according to a dynamic specific to each envelope gene. We further investigate whether changes in promoter methylation of the 5'LTR of these HERVs may contribute to the observed transcriptional variations. Analyses were carried out in purified cytotrophoblasts from one normal first trimester placenta (placenta 1.1), trisomic 21 (T-21) second trimester placentas (placentas 2.1 and 2.2) and normal term placentas (placentas 3.1, 3.2 and 3.3) (for clarity, results from one sample for each time of gestation are shown in Fig. 4).
###end p 54
###begin p 55
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 206 207 206 207 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 208 209 208 209 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 231 232 231 232 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 260 261 260 261 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 284 285 284 285 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
CpG methylation dynamics of envelope-coding HERV 5'LTRs in cytotrophoblasts during pregnancy. (A) Schematic representation of the MaLR[LTR]-ERVWE1[5'LTR], ERVFRDE1[5'LTR] and ERV3[5'LTR] analyzed regions. (B-D) CpG methylation of (B) MaLR[LTR]-ERVWE1[5'LTR], (C) ERVFRDE1[5'LTR] and (D) ERV3[5'LTR]. Methylation was determined by bisulfite sequencing PCR in cytotrophoblasts (CT) at different times of gestation. One sample is represented here for each trimester i.e. CT of first trimester placenta from legally induced abortion (placenta 1.1), second trimester placenta from trisomy 21-affected pregnancy (T21, placenta 2.2) and term placenta from healthy mother (placenta 3.3). Each sample result originates from the same conversion reaction. Each line represents an independent molecule. Methylated CpGs are schematized by black circles and unmethylated CpGs by white circles.
###end p 55
###begin p 56
###xml 80 82 80 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C39">39</xref>
###xml 80 82 80 82 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C39">39</xref></sup>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C57">57</xref>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C57">57</xref></sup>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C58">58</xref>
###xml 430 432 430 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C58">58</xref></sup>
###xml 631 632 631 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
###xml 838 839 838 839 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
###xml 1252 1253 1252 1253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
###xml 1765 1768 1765 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 1826 1828 1826 1828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C59">59</xref>
###xml 1826 1828 1826 1828 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C59">59</xref></sup>
###xml 1966 1968 1966 1968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C59">59</xref>
###xml 1966 1968 1966 1968 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C59">59</xref></sup>
###xml 2039 2041 2039 2041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C59">59</xref>
###xml 2042 2044 2042 2044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C60">60</xref>
###xml 2039 2044 2039 2044 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C59">59</xref>,<xref ref-type="bibr" rid="DSP011C60">60</xref></sup>
###xml 2243 2244 2243 2244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
The bimodal methylation pattern previously observed for the ERVWE1[5'LTR] domain39 and herein shown to equally affect the associated MaLR[LTR] TSE in term villous placenta could have reflected an imprinted regulation of ERVWE1, as was suggested previously.57 This process is regularly mediated by the methylation of one of the two alleles in a parent-of-origin manner and often related to genes involved in placenta morphogenesis.58 However, the bimodal methylation was not clearly observed at all stages of pregnancy. Thus, in the first trimester placenta, the MaLR[LTR]-ERVWE1[5'LTR] was not methylated at all (placenta 1.1 Fig. 4B). Among the two second trimester samples derived from T-21 placentas, placenta 2.1 also showed no methylation at all (not shown), whereas placenta 2.2 presented one fully methylated clone out of 12 (Fig. 4B). In contrast, in all the three CT samples derived from term placenta, the bimodal methylation pattern was clearly observed though with a significant sample-to-sample variation in the proportion of the two methylation patterns. More precisely, the number of methylated clones was 1 out of 12 in placenta 3.1 (not illustrated), 5 out of 12 in placenta 3.2 (not illustrated) and 6 out of 14 in placenta 3.3 (Fig. 4B), respectively. In short, the global amount of methylated CpGs in the MaLR[LTR]-ERVWE1[5'LTR] region varied from 0% in the first trimester placenta to 33.3% at term (as observed in the term placental villi sample). The absence of stability in the bimodal repartition of molecules methylation throughout gestation argues against the proposed imprinting hypothesis. In contrast, the apparent increased frequency of hypermethylated sequences from first trimester to term is consistent with the decrease in ERVWE1 env expression observed between 37 and 40 weeks of gestation.59 In addition, the sample-to-sample variations are compatible with the inter-individual variation observed for the ERVWE1 expression level.59 Consequently, ERVWE1 env mRNA down-regulation in placental dysfunction59,60 could be related to an early remethylation of ERVWE1 promoter. The discovery of a single atypical clone exhibiting a methylated MaLR[LTR] and an unmethylated ERVWE1[5'LTR] in villous placenta (Fig. 3B) may reflect a 'targeted' remethylation process that would deserve further investigation.
###end p 56
###begin p 57
###xml 286 287 286 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C61">61</xref>
###xml 561 563 561 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C61">61</xref></sup>
###xml 609 611 609 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C62">62</xref>
###xml 609 611 609 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C62">62</xref></sup>
Contrary to ERVWE1, ERVFRDE1[5'LTR] was stably unmethylated in normal first and term cytotrophoblasts as well as in second trimester T-21 cytotrophoblasts, as overall methylation in the samples did not exceed 5.7% (0%, 5.7% and 2.7% in placenta 1.1, 2.2 and 3.3, respectively, see Fig. 4C; and 1.3%, 5.6% and 3.3% in placenta 2.1, 3.1 and 3.3, respectively, not illustrated). This stable unmethylation allows a constitutive transcriptional activity but cannot account for transcriptional modulations. Thus, ERVFRDE1 env mRNA progressive decrease along gestation61 and down-regulation in T-21 affected placenta62 might preferentially be linked to a modulation of the transcription factor pool rather than to alteration of the LTR methylation.
###end p 57
###begin p 58
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F4">4</xref>
###xml 882 884 882 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C56">56</xref>
###xml 882 884 882 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C56">56</xref></sup>
###xml 949 950 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F3">3</xref>
###xml 1315 1317 1315 1317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C63">63</xref>
###xml 1318 1320 1318 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C64">64</xref>
###xml 1315 1320 1315 1320 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C63">63</xref>,<xref ref-type="bibr" rid="DSP011C64">64</xref></sup>
###xml 1967 1969 1967 1969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C63">63</xref>
###xml 1970 1972 1970 1972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C64">64</xref>
###xml 1967 1972 1967 1972 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C63">63</xref>,<xref ref-type="bibr" rid="DSP011C64">64</xref></sup>
ERV3 [5'LTR] methylation levels [investigated in one representative CT sample for each stage of pregnancy, i.e. placentas 1.1, 2.2 and 3.3 (Fig. 4D)] were somewhat same during all gestation. Hence, in the U3 region, 29.2% of the CpGs were methylated in the first trimester, 18.2% in the second trimester and 25.4% at term. Still, as in ERVWE1, ERV3[5'LTR] methylation pattern did change. However, these changes were not progressive but more drastically linked to the gestation stage, and differences were more particularly obvious between the first and the second trimester. Indeed and interestingly, ERV3[5'LTR] methylation profile in the first trimester was very similar to the one observed for ERVFRDE1[5'LTR] in blood, i.e. precisely and systematically associated with the TATA box. The fact that this precise promoter methylation has been found for the conventional RANKL gene,56 and herein for two unrelated HERVs (ERV3 and ERVFRDE1, see Fig. 3C), might indicate an important regulation mechanism and would have to be studied further. ERV3 expression in placenta along gestation has been described sparsely. However, under the same hypothesis as proposed above for ERVFRDE1, this methylation pattern could correlate with the faint or absent ERV3 env expression in the first trimester highly proliferative CTs.63,64 In the second trimester CT sample, we could observe lower methylation of these CpGs leading to an unmethylated U3 region in 5 of the 11 sequences. In contrast, a new methylation occurred on the first CpG downstream from the LTR on all clones, which was never methylated in the first trimester. Finally, three methylation patterns were observed in term CTs, which were similar to those of the term villous placenta sample. Thus, over the 15 clones analyzed, 8 were completely unmethylated in the U3 area, whereas the others were methylated along the whole U3 region or only on the first and last CpGs. Correlating with ERV3 env highest expression,63,64 the maximal number of unmethylated ERV3[5'LTR] U3 sequences was found at this stage of pregnancy.
###end p 58
###begin p 59
###xml 258 261 258 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 271 274 271 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
Altogether, these results support the hypothesis that the transcriptional activity of these domesticated proviruses is epigenetically controlled and that methylation might be further involved in the developmentally associated regulation of, at least, ERVWE1 env and ERV3 env transcriptional levels in placenta and possibly of ERV3 env in PBLs. Whether the epigenetic picture observed in the second trimester reflects the 15-25 weeks of amenorrhea or the T-21 pathological context deserves further investigations.
###end p 59
###begin title 60
Association between HERV LTRs methylation and transcriptional activity
###end title 60
###begin p 61
###xml 353 354 353 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F5">5</xref>
To investigate whether a systematic correlation exists between LTRs methylation status and transcriptional activities, we conducted paralleled transcription and methylation analyses in various cell lines, namely BeWo (choriocarcinoma), U937 (monocytes), 85HG66 (astrocytoma) and OVCAR-3 (ovarian carcinoma). Although the situation appears complex (Fig. 5), we identified essentially four situations.
###end p 61
###begin p 62
LTR promoter methylation and derived transcriptional activity. LTR-derived transcriptional activity in cell lines is represented by histograms, and the associated methylation profiles of the U3 promoter region of the LTRs are represented underneath. Real-time qPCR values were normalized by the geometric mean of HPRT and 18S housekeeping genes average and are expressed in copy number/1000 cells or 12.5 ng total RNA (numbers on the top of each bar). The associated methylation profiles were determined by bisulfite sequencing PCR. Each sample result originates from the same conversion reaction by bisulfite. Each line represents an independent molecule. Methylated CpGs are schematized by black circles and unmethylated CpGs by white circles. Percentage values express the global methylation level in the U3 promoter region. MaLR[LTR] methylation percentages are shown in parentheses.
###end p 62
###begin p 63
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
First, there is a strong correlation between transcription and methylation. Thus, ERVWE1 and ERVFRED1 env transcription in placental BeWo cells was correlated with their 5'LTR fully unmethylated status. Similarly, faint transcription (below 2 copies/10 cell) was mostly associated with a high and homogeneous methylation of LTRs (e.g. ERVWE1[5'LTR] in U397 and ERVFRDE1[5'LTR] in OVCAR-3).
###end p 63
###begin p 64
Second, comparison of ERVWE1 LTRs and HW_12[solo LTR] suggests that the absence of expression is highly correlated with a huge methylation for functional LTRs (ERVWE1), in contrast to the HW_12[solo LTR] which displays a significant amount of unmethylated U3 regions in 85HG66 and OVCAR-3 cells. This LTR, which exhibits extremely heterogeneous methylation status, is probably not functional; even if we cannot exclude that the lack of related transcription could be attributed to transcription factors paucity.
###end p 64
###begin p 65
Third, comparison of ERVFRDE1 and HW_4 in 85HG66 suggests different processes impairing the activity of these functional 5'LTRs. ERVFRDE1 lack of expression is surely due to dedicated transcriptional activators deficit rather than methylation as several molecules are unmethylated. In contrast, HW_4 lack of expression could be due to the systematic methylation of the CpGs at the 5'LTR U3/R boundary.
###end p 65
###begin p 66
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C65">65</xref>
###xml 325 327 325 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C65">65</xref></sup>
###xml 435 438 435 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 521 524 521 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">env</italic>
###xml 572 611 572 611 <uri xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xlink:type="simple" xlink:href="http://genome.ucsc.edu/cgi-bin/hgTracks">http://genome.ucsc.edu/cgi-bin/hgTracks</uri>
###xml 758 760 758 760 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C12">12</xref>
###xml 758 760 758 760 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C12">12</xref></sup>
###xml 1363 1365 1363 1365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C66">66</xref>
###xml 1363 1365 1363 1365 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C66">66</xref></sup>
###xml 1344 1362 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The fourth situation, concerning ERV3[5'LTR], is more complex. In U937 cells, the env region was very poorly expressed, although the 5'LTR had, so to say, no methylated CpGs. Yet, this permissive methylation is compatible with the induction of ERV3 env upon U937 stimulation with differentiating agents such as retinoic acid.65 In contrast, in 85HG66, BeWo and to a lesser extent in OVCAR-3, we observed a high expression level of the env region, but meanwhile a strong methylation level of ERV3[5'LTR]. Analysis of ERV3 env containing mRNA using the USCS genome browser (http://genome.ucsc.edu/cgi-bin/hgTracks, chr7:64088622-64104466) suggests the existence of an alternative initiation site in addition to the published initiation site in the ERV3[5'LTR].12 The mRNA AK295189, which has 99.8% identity with the genomic sequence, notably supports this. It encompasses the full-length ERV3 env region, but not the retroviral sequence ahead, and starts about 7240 bp upstream from the ERV3[5'LTR] transcription start site. It is thus conceivable that in the cell lines 85HG66, BeWo and possibly in OVCAR-3, the observed transcription is related to such an alternate mRNA form. Alternatively although uncommon, we cannot exclude that the ERV3 promoter contains methylation-dependent transcription factor binding sites, as recently described for Epstein-Barr virus.66
###end p 66
###begin p 67
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F6">6</xref>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="DSP011F6">6</xref>
ERVWE1 is the only known HERV with a juxtaposed enhancer. This TSE is part of a MaLR LTR, and interestingly, all the MaLR CpG sites are located within the TSE. We were thus interested to know the extent to which methylation of the TSE could influence ERVWE1 transcriptional activity. Progressively 5'deleted MaLR[LTR]-ERVWE1[5'LTR] reporter constructs (simplified 'TSE-U3', 'U3 full-length' and 'U3 minimal' promoters, see Fig. 6A) were gradually methylated, transfected in BeWo cell and analyzed for luciferase activity (Fig. 6B). The TSE-U3 promoter activity was the maximal among the three promoter constructs in unmethylated state, but dropped dramatically when methylated. Thus, after 30 min of methylation (incomplete methylation), we observed a 5.4-fold decrease in comparison with only 3- and 1.8-fold for the U3 full-length and minimal promoters. Still, in this state, the TSE-U3 promoter activity remained the highest with 18.4% of the maximal activity, compared with only 10% for the TSE-deleted construct. Further increase in the methylation time to complete methylation reduced the activities to about the same level, i.e. 12.5% for TSE-U3 promoter, 8.5% for the full-length U3 promoter and 7.6% for the minimal U3 promoter. In line with the observed conjoint methylation status of the MaLR[LTR] and ERVWE1[5'LTR], these results underline the importance of the total absence of methylated CpGs on both LTRs to obtain maximal transcription and, conversely the need of a concomitant methylation of both LTRs for an efficient repression.
###end p 67
###begin p 68
###xml 73 74 73 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 536 537 536 537 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 593 601 593 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 667 675 667 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Effect of CpG methylation on MaLR[LTR]-ERVWE1[5'LTR] promoter strength. (A). Schematic representation of TSE-U3, U3 full-length and U3 minimal promoter constructs. Numbering starts from the first position in ERVWE1 5'LTR. Effective and putative transcription factor binding sites associated with the MaLR[LTR] TSE region (Sp-1, c-myb, GCMA, GATA), with the ERVWE1[5'LTR] U3 5'-subdomain (GATA, Pit-1a, ERalpha, Sp-1, Ap-2 and Oct-1), and CAAT and TATA boxes are indicated by black boxes. CpGs are depicted by circles on vertical bars. (B). Relative promoter activities in BeWo cells following in vitro methylation. pGL-LTR firefly luciferase plasmids were methylated in vitro during 30, 60 and 240 min, with and without -SAM. On the basis of restriction profiles with BstUI enzyme -SAM controls were, as expected, not methylated, and methylation level did not evolve anymore after 60 min indicating a similar methylation at 60 and 240 min. Plasmid methylated during 30 and 240 min and -SAM controls were transfected in BeWo b30 choriocarcinoma cells, which contain all the necessary factors for MaLR[LTR]-ERVWE1[5'LTR] promoter activity. Firefly luciferase activities were normalized to the activity of the co-transfected pRL-TK Renilla luciferase plasmids. The mean and standard deviation from at least three independent experiments are shown and expressed as a percentage of the maximal activity. Promoter activity of the vector backbone represents <0.3% of the larger TSE-U3 construct and <1.3% of the U3 minimal promoter construct (not shown).
###end p 68
###begin title 69
Conclusions
###end title 69
###begin p 70
###xml 1110 1111 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C6">6</xref>
###xml 1110 1111 1110 1111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C6">6</xref></sup>
###xml 1251 1252 1251 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C7">7</xref>
###xml 1251 1252 1251 1252 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C7">7</xref></sup>
###xml 1389 1391 1389 1391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C59">59</xref>
###xml 1392 1394 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C60">60</xref>
###xml 1389 1394 1389 1394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C59">59</xref>,<xref ref-type="bibr" rid="DSP011C60">60</xref></sup>
###xml 1636 1638 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C15">15</xref>
###xml 1636 1638 1636 1638 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C15">15</xref></sup>
###xml 1831 1833 1831 1833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="DSP011C13">13</xref>
###xml 1831 1833 1831 1833 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><xref ref-type="bibr" rid="DSP011C13">13</xref></sup>
Our analyses provide evidence that methylation status of ERVWE1 and other HERV-W LTRs are not related to a family/phylogenetically related process, nor are they systematically correlated with the integration surrounding area. However, they support both tissue- and locus-specific methylation processes for functional LTRs. Still, methylation status seems to differ in relation to the promoter/enhancer role of the LTR or its use as polyadenylation signal. In addition, our results suggest that methylation of HERV LTRs could be involved in the modulation of their activity. Thus, this could be achieved in several ways, through an enhancer/promoter epigenetic co-regulation (e.g. MaLR[LTR] and ERVWE1[5'LTR]) or through a variation in cell proportion with unmethylated LTR (e.g. ERVWE1[5'LTR] in CTs) or else, by targeting preferential CpG sites such as CpGs closed to the TATA box (e.g. ERVFRDE1[5'LTR] in PBL, ERV3[5'LTR] in first trimester CTs). Thus, the selective and temporal unmethylation of ERVWE1[5'LTR] in placenta during the first trimester may allow Syncytin-1-mediated cell differentiation/fusion.6 In contrast, increased methylation at term may limit Syncytin-1 production and consequent cell fusion or putative anti-apoptotic protection7 in accordance with CT limited fusion and higher apoptosis rate. Syncytin-1 transcriptional alterations observed in placental pathologies59,60 could similarly be associated with a temporally deregulated methylation of ERVWE1. Likewise, local methylation of the ERV3 promoter during the first trimester may limit ERV3 Env production and consequent inhibition of early CT proliferation.15 In contrast, hypomethylation of ERV3 promoter in the second trimester or term placenta and in fetal blood cells may allow ERV3 Env expression and consequently, contribute to immunosuppression.13 So, apparently convergent tropism and redundant functions, such as fusion for Syncytin-1 (ERVWE1) and Syncytin-2 (ERVFRDE1) or immunosuppression for Synctin-2 and ERV3-Env, do not strictly match with similar methylation regulation. Sequence determinants and mechanisms involved in LTR methylation need to be further investigated to better understand HERV regulations and deregulations associated with pathologies.
###end p 70
###begin title 71
Funding
###end title 71
###begin p 72
JG and CM are supported by a doctoral fellowship from bioMerieux.
###end p 72
###begin title 73
Acknowledgements
###end title 73
###begin p 74
JG performed most of the experimental work and wrote the manuscript; CM participated in molecular studies on LTR methylation; GO, J-PP and KR participated in the molecular studies on transcriptional activities; VT, PG and J-LF carried out placental and blood collection, and the isolation of trophoblastic and fibroblastic cells. DE-B and FM conceived of the study, participated in its design and coordination, and helped draft the manuscript. We are grateful to F. Magdinier for helpful advice concerning the bisulfite sequencing PCR method and to R. Buckland for helping us to improve the manuscript. This project is part of ADNA (Advanced Diagnostics for New Therapeutic Approaches), a program dedicated to personalized medicine, coordinated by Merieux Alliance and supported by the French public agency, OSEO.
###end p 74
###begin title 75
References
###end title 75
###begin article-title 76
###xml 39 44 <span type="species:ncbi:9606">human</span>
Initial sequencing and analysis of the human genome
###end article-title 76
###begin article-title 77
Endogenous retroviruses and animal reproduction
###end article-title 77
###begin article-title 78
###xml 13 18 <span type="species:ncbi:9606">human</span>
Influence of human endogenous retroviruses on cellular gene expression
###end article-title 78
###begin article-title 79
ERVWE1 (Endogenous Retroviral family W, Env(C7), member 1)
###end article-title 79
###begin article-title 80
###xml 49 54 <span type="species:ncbi:9606">human</span>
Direct involvement of HERV-W Env glycoprotein in human trophoblast cell fusion and differentiation
###end article-title 80
###begin article-title 81
Fusogenic endogenous-retroviral syncytin-1 exerts anti-apoptotic functions in staurosporine-challenged CHO cells
###end article-title 81
###begin article-title 82
###xml 79 84 <span type="species:ncbi:9606">human</span>
Proliferation and cell-cell fusion of endometrial carcinoma are induced by the human endogenous retroviral Syncytin-1 and regulated by TGF-beta
###end article-title 82
###begin article-title 83
###xml 35 62 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution
###end article-title 83
###begin article-title 84
###xml 20 25 <span type="species:ncbi:9606">human</span>
ERV3, a full-length human endogenous provirus: chromosomal localization and evolutionary relationships
###end article-title 84
###begin article-title 85
###xml 10 15 <span type="species:ncbi:9606">human</span>
Survey of human genes of retroviral origin: identification and transcriptome of the genes with coding capacity for complete envelope proteins
###end article-title 85
###begin article-title 86
###xml 30 35 <span type="species:ncbi:9606">human</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
Tissue-specific expression of human provirus ERV3 mRNA in human placenta: two of the three ERV3 mRNAs contain human cellular sequences
###end article-title 86
###begin article-title 87
Placental syncytins: genetic disjunction between the fusogenic and immunosuppressive activity of retroviral envelope proteins
###end article-title 87
###begin article-title 88
###xml 70 75 <span type="species:ncbi:9606">human</span>
Expression of the fusogenic HERV-FRD Env glycoprotein (syncytin 2) in human placenta is restricted to villous cytotrophoblastic cells
###end article-title 88
###begin article-title 89
###xml 36 63 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 126 131 <span type="species:ncbi:9606">human</span>
The cellular mechanism by which the human endogenous retrovirus ERV-3 env gene affects proliferation and differentiation in a human placental trophoblast model, BeWo
###end article-title 89
###begin article-title 90
###xml 14 41 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Expression of human endogenous retrovirus ERV3 (HERV-R) mRNA in normal and neoplastic tissues
###end article-title 90
###begin article-title 91
###xml 46 52 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Developmental expression of HERV-R (ERV3) and HERV-K in human tissue
###end article-title 91
###begin article-title 92
Identification and characterization of a family of mammalian methyl-CpG binding proteins
###end article-title 92
###begin article-title 93
CpG methylation of the cAMP-responsive enhancer/promoter sequence TGACGTCA abolishes specific factor binding as well as transcriptional activation
###end article-title 93
###begin article-title 94
Cytosine methylation and the ecology of intragenomic parasites
###end article-title 94
###begin article-title 95
###xml 61 66 <span type="species:ncbi:9606">human</span>
The 5-methylcytosine content of highly repeated sequences in human DNA
###end article-title 95
###begin article-title 96
###xml 26 31 <span type="species:ncbi:9606">human</span>
Methylation of endogenous human retroelements in health and disease
###end article-title 96
###begin article-title 97
###xml 24 29 <span type="species:ncbi:9606">human</span>
DNA hypomethylation and human diseases
###end article-title 97
###begin article-title 98
###xml 67 94 <span type="species:ncbi:11827">human endogenous retrovirus</span>
###xml 102 108 <span type="species:ncbi:45617?0.9032258064516129">HERV-K</span>
CpG methylation directly regulates transcriptional activity of the human endogenous retrovirus family HERV-K(HML-2)
###end article-title 98
###begin article-title 99
###xml 14 43 <span type="species:ncbi:45617">human endogenous retrovirus-K</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Regulation of human endogenous retrovirus-K Gag expression in teratocarcinoma cell lines and human tumours
###end article-title 99
###begin article-title 100
###xml 99 104 <span type="species:ncbi:9606">human</span>
Possible role of DNA hypomethylation in the induction of SLE: relationship to the transcription of human endogenous retroviruses
###end article-title 100
###begin article-title 101
###xml 72 80 <span type="species:ncbi:9606">patients</span>
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis
###end article-title 101
###begin article-title 102
###xml 48 75 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Monocyte activation and differentiation augment human endogenous retrovirus expression: implications for inflammatory brain diseases
###end article-title 102
###begin article-title 103
Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia
###end article-title 103
###begin article-title 104
###xml 61 69 <span type="species:ncbi:9606">patients</span>
A new endogenous retroviral sequence is expressed in skin of patients with psoriasis
###end article-title 104
###begin article-title 105
###xml 31 36 <span type="species:ncbi:9606">human</span>
Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues
###end article-title 105
###begin article-title 106
###xml 65 92 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Multiplex degenerate PCR coupled with an oligo sorbent array for human endogenous retrovirus expression profiling
###end article-title 106
###begin article-title 107
###xml 14 19 <span type="species:ncbi:9606">human</span>
Expression of human endogenous gammaretroviral sequences in endometriosis and ovarian cancer
###end article-title 107
###begin article-title 108
###xml 23 50 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Expression of multiple human endogenous retrovirus surface envelope proteins in ovarian cancer
###end article-title 108
###begin article-title 109
Expression of an endogenous retroviral sequence from the HERV-H group in gastrointestinal cancers
###end article-title 109
###begin article-title 110
###xml 45 60 <span type="species:ncbi:45617">HERV-K provirus</span>
DNA methylation and expression of LINE-1 and HERV-K provirus sequences in urothelial and renal cell carcinomas
###end article-title 110
###begin article-title 111
###xml 53 58 <span type="species:ncbi:9606">human</span>
L1 and HERV-W retrotransposons are hypomethylated in human ovarian carcinomas
###end article-title 111
###begin article-title 112
###xml 60 65 <span type="species:ncbi:9606">human</span>
Widely variable endogenous retroviral methylation levels in human placenta
###end article-title 112
###begin article-title 113
###xml 55 60 <span type="species:ncbi:9606">human</span>
CpG methylation suppresses transcriptional activity of human syncytin-1 in non-placental tissues
###end article-title 113
###begin article-title 114
###xml 51 78 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Characterization of the intragenomic spread of the human endogenous retrovirus family HERV-W
###end article-title 114
###begin article-title 115
###xml 25 30 <span type="species:ncbi:9606">human</span>
Processed pseudogenes of human endogenous retroviruses generated by LINEs: their integration, stability, and distribution
###end article-title 115
###begin article-title 116
###xml 69 96 <span type="species:ncbi:11827">human endogenous retrovirus</span>
Molecular characterization and placental expression of HERV-W, a new human endogenous retrovirus family
###end article-title 116
###begin article-title 117
A retroviral promoter and a cellular enhancer define a bipartite element which controls env ERVWE1 placental expression
###end article-title 117
###begin article-title 118
###xml 36 41 <span type="species:ncbi:9606">human</span>
A placenta-specific enhancer of the human syncytin gene
###end article-title 118
###begin article-title 119
The endogenous retroviral locus ERVWE1 is a bona fide gene involved in hominoid placental physiology
###end article-title 119
###begin article-title 120
Natural history of the ERVWE1 endogenous retroviral locus
###end article-title 120
###begin article-title 121
Defect of villous cytotrophoblast differentiation into syncytiotrophoblast in Down's syndrome
###end article-title 121
###begin article-title 122
###xml 59 64 <span type="species:ncbi:9606">human</span>
Overexpression of copper zinc superoxide dismutase impairs human trophoblast cell fusion and differentiation
###end article-title 122
###begin article-title 123
###xml 20 25 <span type="species:ncbi:9606">human</span>
Characterization of human villous and extravillous trophoblasts isolated from first trimester placenta
###end article-title 123
###begin article-title 124
###xml 100 105 <span type="species:ncbi:9606">human</span>
Expression of HERV-W Env glycoprotein (syncytin) in the extravillous trophoblast of first trimester human placenta
###end article-title 124
###begin article-title 125
###xml 60 94 <span type="species:ncbi:11908">human T-cell leukemia virus type 1</span>
5'-long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo
###end article-title 125
###begin article-title 126
###xml 73 78 <span type="species:ncbi:11676?0.8769782024484921">HIV-1</span>
5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals
###end article-title 126
###begin article-title 127
Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis
###end article-title 127
###begin article-title 128
###xml 12 17 <span type="species:ncbi:9606">human</span>
The role of human endogenous retroviruses in trophoblast differentiation and placental development
###end article-title 128
###begin article-title 129
Methylation status of a single CpG locus 3 bases upstream of TATA-box of receptor activator of nuclear factor-kappaB ligand (RANKL) gene promoter modulates cell- and tissue-specific RANKL expression and osteoclastogenesis
###end article-title 129
###begin article-title 130
###xml 100 105 <span type="species:ncbi:9606">human</span>
Temporal regulation of the expression of syncytin (HERV-W), maternally imprinted PEG10, and SGCE in human placenta
###end article-title 130
###begin article-title 131
Genomic imprinting: parental influence on the genome
###end article-title 131
###begin article-title 132
Altered placental syncytin and its receptor ASCT2 expression in placental development and pre-eclampsia
###end article-title 132
###begin article-title 133
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 54 59 <span type="species:ncbi:9606">human</span>
Syncytin, a novel human endogenous retroviral gene in human placenta: evidence for its dysregulation in preeclampsia and HELLP syndrome
###end article-title 133
###begin article-title 134
###xml 23 28 <span type="species:ncbi:9606">human</span>
Expression analyses of human endogenous retroviruses (HERVs): tissue-specific and developmental stage-dependent expression of HERVs
###end article-title 134
###begin article-title 135
###xml 0 27 <span type="species:ncbi:11827">Human endogenous retrovirus</span>
Human endogenous retrovirus-FRD envelope protein (syncytin 2) expression in normal and trisomy 21-affected placenta
###end article-title 135
###begin article-title 136
###xml 4 31 <span type="species:ncbi:11827">human endogenous retrovirus</span>
The human endogenous retrovirus ERV-3 is upregulated in differentiating placental trophoblast cells
###end article-title 136
###begin article-title 137
###xml 56 61 <span type="species:ncbi:9606">human</span>
Expression of an endogenous retrovirus (ERV3 HERV-R) in human reproductive and embryonic tissues-evidence for a function for envelope gene products
###end article-title 137
###begin article-title 138
Expression of the endogenous retrovirus ERV3 (HERV-R) during induced monocytic differentiation in the U-937 cell line
###end article-title 138
###begin article-title 139
###xml 37 55 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters
###end article-title 139
###begin p 140
Edited by Minoru Ko
###end p 140

